Correlation Between Spero Therapeutics and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spero Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on Spero Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and Terns Pharmaceuticals.
Diversification Opportunities for Spero Therapeutics and Terns Pharmaceuticals
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Spero and Terns is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Spero Therapeutics and Terns Pharmaceuticals
Given the investment horizon of 90 days Spero Therapeutics is expected to under-perform the Terns Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Spero Therapeutics is 1.84 times less risky than Terns Pharmaceuticals. The stock trades about 0.0 of its potential returns per unit of risk. The Terns Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 544.00 in Terns Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of 71.00 from holding Terns Pharmaceuticals or generate 13.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spero Therapeutics vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Spero Therapeutics |
| Terns Pharmaceuticals |
Spero Therapeutics and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spero Therapeutics and Terns Pharmaceuticals
The main advantage of trading using opposite Spero Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Spero Therapeutics vs. Candel Therapeutics | Spero Therapeutics vs. Cingulate Warrants | Spero Therapeutics vs. Unicycive Therapeutics | Spero Therapeutics vs. Cardio Diagnostics Holdings |
| Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Correlations Find global opportunities by holding instruments from different markets |